WE ENVISION A WORLD WHERE WOMEN LIVE LONGER AND HEALTHIER LIVES BECAUSE OVARIAN CANCER CAN BE PREVENTED, CAUGHT EARLY, OR CURED.
Executive compensation, broken down
Form 990 · Schedule J · 2 reported individuals · Filing year 2024
- Base
- $162k
- Bonus
- —
- Other
- —
- Benefits
- $24k
| Position | Base | Bonus | Other | Benefits | Total |
|---|---|---|---|---|---|
CEO | $162k | — | — | $24k | $186k $198k |
Development Director (until 4/2024) | — | — | — | — | $35k $37k |
Teal figures restate each filed amount in 2026 dollars.
Estimated with Seattle-Tacoma-Bellevue, WA metro-area CPI-U, restating filed pay into April 2026 dollars. A restatement of past pay, not current or projected pay.
Plus 12 unpaid individuals.
Up 1%
from 2023
From $183k in 2023 to $186k in 2024.
Estimated with Seattle-Tacoma-Bellevue, WA metro-area CPI-U, restating filed pay into April 2026 dollars. A restatement of past pay, not current or projected pay.
Revenue and expenses over time
RIVKIN CENTER FOR OVARIAN CANCER reported revenue and expenses across 2 filing years.
What Medical Research executives earn
Comparable medical research organizations nationwide pay their highest-earning executive a median of $114,840.
These are medical research sector-wide figures, not this organization's reported pay. Based on 283 organizations across 283 filings (2021 – 2023).
See full Medical Research compensation data →Compare any role, sector, or revenue band
Build your own benchmark from millions of reported positions.